Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
James Moore
University of Colorado Denver, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Bristol Myers Squibb Pharmaceutical
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Dr. Moore has a significant financial interest because he owns stock in Bristol Myers Squibb Pharmaceutical; the value of the stock is greater than (b)(4). Bristol Myers Squibb Pharmaceutical is the manufacturer of the study drug.
University of Colorado NTCN Lead Academic Participating Site (LAPS)
As the only NCI-designated Cancer Center in the State of Colorado, the UCCC innovates in the development of more effective approaches to prevention, diagnosis, and therapy of cancer. Clinical trials, especially Phase III studies, drive progress and establish new standards of care (SOC). This grant provides essential resources to support these clinical trials to our Cancer Center and to multiple sites around the Rocky Mountain region. Access to clinical trials is crucial for excellence in health care.
Filed on June 22, 2017.
Tell us what you know about James Moore's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “James Moore”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| James Moore | Georgia Institute of Technology | Conflict of Interest | OnTheMarkWeather | |
| James Moore | University of Colorado Denver | Conflict of Interest | Bristol Myers Squibb Pharmaceutical | $5,000 - $9,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.